Anthony Fauci, MD: The human phase-1 on trial on the Ebola vaccine was started on Sept. 2nd and it was slated for 20 normal volunteers to receive the vaccine. Thus far, 10 have received it. The primary purpose, as in all phase 1 studies, is to determine fundamentally: Is it safe? Namely, are there or not, any adverse, unexpected reactions to the vaccine themselves? Thus far, there has been nothing that would be a red flag. The secondary question that’s asked: Does it induce the kind of immune response that you would predict would be protected? Because the human study, the small phase 1, 20-person human study, was based on a study in an animal model, in a monkey, in which that same vaccine was used in the monkey, and the monkeys were challenged with a lethal dose of Ebola, and the monkeys that were vaccinated were protected, and the monkeys that were not vaccinated, all died. And they gave a certain immune response. So, we’re trying to find out in this small, preliminary, 20-person study: Is it safe and does it induce that same kind of immune response that we saw in the animal? Honestly, the question of whether this vaccine, if it turns out to be safe and if it does induce the kind of immune response that you would hope it would be, I don’t think it would be quote, “ready” for this epidemic to have an impact on turning the epidemic around, for a number of reasons. Because, you don’t know if it works and the worst thing in the world, is to at the end of all this, have a vaccine that A, you don’t know it works, and B, you don’t know if you’ve done any harm. So, what likely will happen is that the vaccine will go into the next phase of a clinical trial. And by the next phase we mean, instead of 20 people, in a phase 1 trial, there’ll be hundreds, if not thousands of people, in some sort of a trial. So it’s got to be scientifically sound, and it’s got to be ethically sound. So even in the process of a clinical trial, you may be able to get access to people who might benefit, but if you don’t do it in the context of a clinical trial, then you’re actually blind to what the results are. You just know you’ve given something and you have no idea if it works, no idea if it harms.